BamSEC and AlphaSense Join Forces
Learn More

KALA BIO Inc. – Transcripts

NASDAQ: KALA    
Share price (8/20/26): $0.84    
Market cap (8/20/26): $16.2 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2025
Other Revised 07/29/25 KALA BIO, Inc. - Special Call 07/16/25
CY 2022
Earnings Revised 08/11/22 Kala Pharmaceuticals, Inc., Q2 2022 Earnings Call, Aug 11, 2022 08/11/22
Earnings Revised 05/16/22 Kala Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 16, 2022 05/16/22
Earnings Revised 03/29/22 Kala Pharmaceuticals, Inc., Q4 2021 Earnings Call, Mar 29, 2022 03/29/22
CY 2021
Earnings Revised 11/15/21 Kala Pharmaceuticals, Inc., Q3 2021 Earnings Call, Nov 15, 2021 11/15/21
Earnings Revised 08/05/21 Kala Pharmaceuticals, Inc., Q2 2021 Earnings Call, Aug 05, 2021 08/05/21
Other Revised 05/13/21 Kala Pharmaceuticals, Inc. Presents at BofA Securities 2021 Virtual Health Care Conference, May-13-2021 04:15 PM 05/13/21
Earnings Revised 05/05/21 Kala Pharmaceuticals, Inc., Q1 2021 Earnings Call, May 05, 2021 05/05/21
Earnings Revised 02/25/21 Kala Pharmaceuticals, Inc., Q4 2020 Earnings Call, Feb 25, 2021 02/25/21
Other Revised 01/13/21 Kala Pharmaceuticals, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-13-2021 06:10 AM 01/13/21
CY 2020
Earnings Revised 11/05/20 Kala Pharmaceuticals, Inc., Q3 2020 Earnings Call, Nov 05, 2020 11/05/20
Other Revised 10/27/20 Kala Pharmaceuticals, Inc. - Special Call 10/27/20
Other Revised 09/17/20 Kala Pharmaceuticals, Inc. - Special Call 09/17/20
Earnings Revised 08/06/20 Kala Pharmaceuticals, Inc., Q2 2020 Earnings Call, Aug 06, 2020 08/06/20
Other Revised 06/25/20 Kala Pharmaceuticals, Inc. - Shareholder/Analyst Call 06/25/20
Other Revised 05/13/20 Kala Pharmaceuticals, Inc. Presents at BofA Securities 2020 Health Care Conference, May-13-2020 04:20 PM 05/13/20
Earnings Revised 05/07/20 Kala Pharmaceuticals, Inc., Q1 2020 Earnings Call, May 07, 2020 05/07/20
Other Revised 03/09/20 Kala Pharmaceuticals, Inc. - Special Call 03/09/20
Earnings Revised 02/12/20 Kala Pharmaceuticals, Inc., Q4 2019 Earnings Call, Feb 12, 2020 02/12/20
Other Revised 01/15/20 Kala Pharmaceuticals, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-15-2020 11:30 AM 01/15/20
CY 2019
Earnings Revised 11/07/19 Kala Pharmaceuticals, Inc., Q3 2019 Earnings Call, Nov 07, 2019 11/07/19
Earnings Revised 08/06/19 Kala Pharmaceuticals, Inc., Q2 2019 Earnings Call, Aug 06, 2019 08/06/19
Other Revised 05/14/19 Kala Pharmaceuticals, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-14-2019 08:15 AM 05/14/19
Earnings Revised 05/09/19 Kala Pharmaceuticals, Inc., Q1 2019 Earnings Call, May 09, 2019 05/09/19
Earnings Revised 03/11/19 Kala Pharmaceuticals, Inc., Q4 2018 Earnings Call, Mar 11, 2019 03/11/19
Other Revised 01/07/19 Kala Pharmaceuticals, Inc. Presents at The 37th Annual J.P. Morgan Healthcare Conference, Jan-07-2019 through Jan-10-2019 01/07/19
CY 2018
Other Revised 09/12/18 Kala Pharmaceuticals, Inc. Presents at Morgan Stanley 16th Annual Global Healthcare Conference, Sep-12-2018 05:25 PM 09/12/18
Other Revised 08/23/18 Kala Pharmaceuticals, Inc. - Special Call 08/23/18
Other Revised 05/15/18 Kala Pharmaceuticals, Inc. Presents at Bank of America Merrill Lynch 2018 Healthcare Conference, May-15-2018 11:35 AM 05/15/18
Earnings Revised 03/26/18 Kala Pharmaceuticals, Inc., Q4 2017 Earnings Call, Mar 26, 2018 03/26/18
Other Revised 01/08/18 Kala Pharmaceuticals, Inc. Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-08-2018 11:30 AM 01/08/18
Other Revised 01/05/18 Kala Pharmaceuticals, Inc. - Special Call 01/05/18